Last December the Institute for NanoBioTechnology placed a call for proposals in the area of therapeutics. This was the third funding opportunity supported by INBT in one of it’s core research areas. Five winning proposals by Johns Hopkins faculty have been selected to receive $15,000 – $25,000 each.
The winners are:
- Corrolazine nanoparticles for photodynamic therapy and magnetic resonance imaging by David Goldberg (Chemistry), Jeff Bulte (Radiology), & Anirban Maitra (Pathology/Oncology)
- Bone-targeted biodegradable nano-spheres for localized treatment of skeletal disease by Scott Kominsky (Orthopaedic Surgery/Oncology), Justin Hanes (Chemical & Biomolecular Eng), & Kristy Weber (Orthopaedic Surgery/Oncology)
- Selective prodrug activation in cancer cells using protein switches by Marc Ostermeier (Chemical & Biomolecular Engr), James Eshleman (Pathology/Oncology), & Craig Townsend (Chemistry)
- Quantum dots as artificial antigen-presenting cells (aAPC) for tumor immunotherapy by Jonathan Schneck (Pathology), & Michael Edidin (Biology)
- In vivo evaluation of sugar-SCFA nanoparticles by Kevin Yarema (Biomedical Engr) & Henry Brem (Neurosurgery) by